The Human Erythrocyte Insulin-Like Growth Factor I Receptor:Characterization and Demonstration of Ligand-Stimulated Autophosphorylation
- 1 April 1986
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 62 (4) , 692-699
Abstract
To characterize the insulin-like growth factor I (IGF-I) receptor on human erythrocytes, cells were purified from peripheral blood by Ficoll-Hypaque gradient centrifugation and incubated with [125I]IGF-I. Specific binding was maximal at pH 8.0 after 24 h at 4 C and increased linearly with cell number to 3.9 ± 0.2% (±SEM) for 3.0 × 10(9)cells/ml. The Scatchard plot of the binding data was linear, with 7 fmol [125I]IGF-I bound/109cells and an affinity constant (K) of 1.8 × 109 M−1.Unlabele d IGF-I inhibited tracer binding half-maximally at 6 ng/ml. Multiplication-stimulating activity (or rat IGF-II) was 40% as potent (ED50, 15 ng/ml), whereas insulin and proinsulin were 30- to 500-fold less potent. A monoclonal antibody to the IGF-I receptor (αIR-3) inhibited IGF-I binding by 50% at a 1:1000 dilution and by 80% at a 1:250 dilution. Insulin binding was unaffected by the same dilutions. IGF-I receptor phosphorylation was studied in erythrocyteghosts prepared by hypotonic lysis and solubilized in 1% Triton. The extract was preincubated with and without 100 ng⁄ml IGF-I or porcine insulin and incubated with [γ−32 P] ATP in the presence of Mn2+, and the receptor was identified by immuno-precipitation with αIR-3 antibody and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. IGF-I stimulated 4-fold the incorporation of 32P into a protein of 95,000 mol wt, which was immunoprecipitated by αIR-3; insulin produced a 2-fold stimulation of this protein. This protein corresponds to the β-subunit of the IGF-I receptor. These data demonstrate that human erythrocytes have specific receptors for IGF-I, and that this IGF-I receptor, like the insulin receptor, undergoes ligand-stimulated autophosphoryla-tion. Thus, analysis of erythrocyte IGF-I binding and receptor phosphorylation may be useful tools for the study of patients with a variety of growth disorders. (J Clin Endocrinol Metab62: 692,1986)Keywords
This publication has 27 references indexed in Scilit:
- Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking.Journal of Biological Chemistry, 1981
- Characterization of a Specific Receptor for Somatomedin C (SM-C) on Cultured Human Lymphocytes: Evidence that SM-C Modulates Homologous Receptor Concentration*Endocrinology, 1980
- Interactions of Insulin-Like Growth Factors I and II and Multiplication-Stimulating Activity with Receptors and Serum Carrier ProteinsEndocrinology, 1980
- Purification and Characterization of Multiplication‐Stimulating ActivityEuropean Journal of Biochemistry, 1980
- Increased Insulin Binding to Erythrocytes in Anorexia NervosaNew England Journal of Medicine, 1979
- Characteristics of human erythrocyte insulin receptorsDiabetes, 1978
- Enzymatic synthesis and rapid translocation of phosphatidylcholine by two methyltransferases in erythrocyte membranes.Proceedings of the National Academy of Sciences, 1978
- The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.Journal of Biological Chemistry, 1978
- Identification of a Receptor for Somatomedin-Like Polypeptides in Human Fibroblasts*The Journal of Clinical Endocrinology & Metabolism, 1977
- Specific 125I-somatomedin receptor on circulating human mononuclear cellsBiochemical and Biophysical Research Communications, 1977